A recent study by Schwimmer et al. demonstrated, a 57 % sensitivity of ALT for the detection of NAFLD or NASH (10) and NASH and NAFLD also appear in patients with normal AST or ALT (11). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.